(1) Trautmann, S., Rehm, J., & Wittchen, H. U. (2016). The economic costs of mental disorders. EMBO reports, 17(9), 1245-1249. https://www.ncbi.nlm.nih.gov/pubmed/27491723
(2) Wittchen, H.U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C.L.F.P.J. and Fratiglioni, L., 2011. The size and burden of mental disorders and other disorders of the brain in Europe 2010. European neuropsychopharmacology, 21(9), 655-679. https://www.ncbi.nlm.nih.gov/pubmed/21896369
(3) Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. U. (2012). Twelve‐month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. International journal of methods in psychiatric research, 21(3), 169-184. https://www.ncbi.nlm.nih.gov/pubmed/22865617
(4) Mental Health and Illness. (n.d.). Retrieved from https://www.cph.co.nz/your-health/mental-illness/
(5) Andrade, L.H., Alonso, J., Mneimneh, Z., Wells, J.E., Al-Hamzawi, A., Borges, G., Bromet, E., Bruffaerts, R., De Girolamo, G., De Graaf, R. and Florescu, S., 2014. Barriers to mental health treatment: results from the WHO World Mental Health surveys. Psychological medicine, 44(6), pp.1303-1317.
(6) Schiffman, S. S., Gill, J. M., & Diaz, C. (1985). Methyl xanthines enhance taste: Evidence for modulation of taste by adenosine receptor. Pharmacology Biochemistry and Behavior, 22(2), 195-203. https://www.ncbi.nlm.nih.gov/pubmed/2580320.
(7) American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association, 2013.
(8) Gureje, O., Nortje, G., Makanjuola, V., Oladeji, B. D., Seedat, S., & Jenkins, R. (2015). The role of global traditional and complementary systems of medicine in the treatment of mental health disorders. The Lancet Psychiatry, 2(2), 168-177. https://www.ncbi.nlm.nih.gov/pubmed/26359753
(9) Nehlig, A. (2013). The neuroprotective effects of cocoa flavanol and its influence on cognitive performance. British journal of clinical pharmacology, 75(3), 716-727. https://www.ncbi.nlm.nih.gov/pubmed/22775434
(10) Kim, J., Kim, J., Shim, J., Lee, C. Y., Lee, K. W., & Lee, H. J. (2014). Cocoa phytochemicals: recent advances in molecular mechanisms on health. Critical reviews in food science and nutrition, 54(11), 1458-1472. https://www.ncbi.nlm.nih.gov/pubmed/24580540
(11) Franco, R., Oñatibia-Astibia, A., & Martínez-Pinilla, E. (2013). Health benefits of methylxanthines in cacao and chocolate. Nutrients, 5(10), 4159-4173. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820066/
(12) Vauzour, D., Vafeiadou, K., Rodriguez-Mateos, A., Rendeiro, C., & Spencer, J. P. (2008). The neuroprotective potential of flavonoids: a multiplicity of effects. Genes & nutrition, 3(3), 115. https://www.ncbi.nlm.nih.gov/pubmed/18937002
(13) Letenneur, L., Proust-Lima, C., Le Gouge, A., Dartigues, J. F., & Barberger-Gateau, P. (2007). Flavonoid intake and cognitive decline over a 10-year period. American journal of epidemiology, 165(12), 1364-1371. https://www.ncbi.nlm.nih.gov/pubmed/17369607
(14) Verstraeten, S. V., Keen, C. L., Schmitz, H. H., Fraga, C. G., & Oteiza, P. I. (2003). Flavan-3-ols and procyanidins protect liposomes against lipid oxidation and disruption of the bilayer structure. Free Radical Biology and Medicine, 34(1), 84-92.
(15) Liu, X., Smith, B. J., Chen, C., Callegari, E., Becker, S. L., Chen, X., ... & Hosea, N. (2005). Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding. Journal of Pharmacology and Experimental Therapeutics, 313(3), 1254-1262. https://www.ncbi.nlm.nih.gov/pubmed/15743928
(16) El Mohsen, M. M. A., Kuhnle, G., Rechner, A. R., Schroeter, H., Rose, S., Jenner, P., & Rice-Evans, C. A. (2002). Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radical Biology and Medicine, 33(12), 1693-1702. https://www.ncbi.nlm.nih.gov/pubmed/12488137
(17) Francis, S. T., Head, K., Morris, P. G., & Macdonald, I. A. (2006). The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. Journal of cardiovascular pharmacology, 47, S215-S220.
(18) Xie, L., Kang, H., Xu, Q., Chen, M.J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D.J., Nicholson, C., Iliff, J.J. and Takano, T., 2013. Sleep drives metabolite clearance from the adult brain. science, 342(6156), pp.373-377. https://www.ncbi.nlm.nih.gov/pubmed/24136970
(19) Pérez-Jiménez, J., Neveu, V., Vos, F., & Scalbert, A. (2010). Identification of the 100 richest dietary sources of polyphenols: an application of the Phenol-Explorer database. European journal of clinical nutrition, 64(S3), S112. http://phenol-explorer.eu/contents/food/536
(20) Schroeter, H., Heiss, C., Balzer, J., Kleinbongard, P., Keen, C. L., Hollenberg, N. K., ... & Kelm, M. (2006). (–)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proceedings of the National Academy of Sciences, 103(4), 1024-1029.
21) Hasler, G., Fromm, S., Alvarez, R. P., Luckenbaugh, D. A., Drevets, W. C., & Grillon, C. (2007). Cerebral blood flow in immediate and sustained anxiety. Journal of Neuroscience, 27(23), 6313-6319. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713601/
(22) Chapman, S. B., Aslan, S., Spence, J. S., Hart Jr, J. J., Bartz, E. K., Didehbani, N., ... & Lu, H. (2013). Neural mechanisms of brain plasticity with complex cognitive training in healthy seniors. Cerebral cortex, 25(2), 396-405. https://www.ncbi.nlm.nih.gov/pubmed/23985135
(23) Mozolic, J. L., Hayaska, S., & Laurienti, P. J. (2010). A cognitive training intervention increases resting cerebral blood flow in healthy older adults. Frontiers in human neuroscience, 4, 16. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841485/
(24) Socci, V., Tempesta, D., Desideri, G., De Gennaro, L., & Ferrara, M. (2017). Enhancing human cognition with cocoa flavonoids. Frontiers in nutrition, 4, 19. https://www.ncbi.nlm.nih.gov/pubmed/28560212
(25) Crews WD, Harrison DW, Wright JW. A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults. Am J Clin Nutr (2008) 87:872–80.
(26) Camfield DA, Scholey A, Pipingas A, Silberstein R, Kras M, Nolidin K, et al. Steady state visually evoked potential (SSVEP) topography changes associated with cocoa flavanol consumption. Physiol Behav (2012) 105:948–57. doi:10.1016/j.physbeh.2011.11.013
(27) Desideri G, Kwik-Uribe C, Grassi D, Necozione S, Ghiadoni L, Mastroiacovo D, et al. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) Study. Hypertension (2012) 60:794–801. doi:10.1161/HYPERTENSIONAHA.112.193060
(28) Sorond FA, Hurwitz S, Salat DH, Greve DN, Fisher ND. Neurovascular coupling, cerebral white matter integrity, and response to cocoa in older people. Neurology (2013) 81:904–9. doi:10.1212/WNL.0b013e3182a351aa
(29) Brickman AM, Khan UA, Provenzano FA, Yeung LK, Suzuki W, Schroeter H, et al. Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults. Nat Neurosci (2014) 17:1798–803. doi:10.1038/nn.3850
(30) Mastroiacovo D, Kwik-Uribe C, Grassi D, Necozione S, Raffaele A, Pistacchio L, et al. Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the Cocoa, Cognition, and Aging (CoCoA) Study—a randomized controlled trial. Am J Clin Nutr (2015) 101:538–48. doi:10.3945/ajcn.114.092189
(31) Neshatdoust S, Saunders C, Castle SM, Vauzour D, Williams C, Butler L, et al. High-flavonoid intake induces cognitive improvements linked to changes in serum brain-derived neurotrophic factor: two randomised, controlled trials. Nutr Healthy Aging (2016) 24:81–93. doi:10.3233/NHA-1615
(32) Messaoudi, M., Bisson, J. F., Nejdi, A., Rozan, P., & Javelot, H. (2008). Antidepressant-like effects of a cocoa polyphenolic extract in Wistar–Unilever rats. Nutritional neuroscience, 11(6), 269-276.
(33) Massee, L. A., Ried, K., Pase, M., Travica, N., Yoganathan, J., Scholey, A., ... & Pipingas, A. (2015). The acute and sub-chronic effects of cocoa flavanols on mood, cognitive and cardiovascular health in young healthy adults: a randomized, controlled trial. Frontiers in pharmacology, 6, 93. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438591/
(34) Hammerstone, J. F., Lazarus, S. A., Mitchell, A. E., Rucker, R., & Schmitz, H. H. (1999). Identification of procyanidins in cocoa (Theobroma cacao) and chocolate using high-performance liquid chromatography/mass spectrometry. Journal of Agricultural and Food Chemistry, 47(2), 490-496. https://www.ncbi.nlm.nih.gov/pubmed/10563922
(35) Craig, W. J., & Nguyen, T. T. (1984). Caffeine and theobromine levels in cocoa and carob products. Journal of Food Science, 49(1), 302-303.
(36) Belščak, A., Komes, D., Horžić, D., Ganić, K. K., & Karlović, D. (2009). Comparative study of commercially available cocoa products in terms of their bioactive composition. Food Research International, 42(5-6), 707-716. https://pubag.nal.usda.gov/catalog/755780
(37) Wollgast, J., & Anklam, E. (2000). Review on polyphenols in Theobroma cacao: changes in composition during the manufacture of chocolate and methodology for identification and quantification. Food Research International, 33(6), 423-447.
(38) Oracz, J., Nebesny, E., & Żyżelewicz, D. (2015). Changes in the flavan-3-ols, anthocyanins, and flavanols composition of cocoa beans of different Theobroma cacao L. groups affected by roasting conditions. European Food Research and Technology, 241(5), 663-681.
(39) Islam, R., Matsuzaki, K., Sumiyoshi, E., Hossain, M.E., Hashimoto, M., Katakura, M., Sugimoto, N. and Shido, O., 2019. Theobromine Improves Working Memory by Activating the CaMKII/CREB/BDNF Pathway in Rats. Nutrients, 11(4), p.888. https://www.ncbi.nlm.nih.gov/pubmed/31010016
(40) Di Tomaso, E., Beltramo, M., & Piomelli, D. (1996). Brain cannabinoids in chocolate. Nature, 382(6593), 677. https://www.ncbi.nlm.nih.gov/pubmed/8751435
(41) Di Marzo, V., Sepe, N., De Petrocellis, L., Berger, A., Crozier, G., Fride, E., & Mechoulam, R. (1998). Trick or treat from food endocannabinoids?. Nature, 396(6712), 636. https://www.ncbi.nlm.nih.gov/pubmed/9872309
(42) Yamada, T., Yamada, Y., Okano, Y., Terashima, T., & Yokogoshi, H. (2009). Anxiolytic effects of short-and long-term administration of cacao mass on rat elevated T-maze test. The Journal of nutritional biochemistry, 20(12), 948-955.
(43) Irsfeld, M., Spadafore, M., & Prüß, B. M. (2013). β-phenylethylamine, a small molecule with a large impact. Webmedcentral, 4(9).
(44) Melzig, M. F., Putscher, I., Henklein, P., & Haber, H. (2000). In vitro pharmacological activity of the tetrahydroisoquinoline salsolinol present in products from Theobroma cacao L. like cocoa and chocolate. Journal of ethnopharmacology, 73(1-2), 153-159.